Literature DB >> 17098565

Prognosis research: why is Dr. Lydgate still waiting?

Harry Hemingway1.   

Abstract

BACKGROUND: Understanding prognosis--the future risk of adverse outcomes among people with existing disease--plays third fiddle behind clinical research into therapeutic interventions and novel diagnostic technologies. METHODS AND
RESULTS: Diseases show marked variations in a wide range of prognostic outcomes, yet these variations have seldom been the subject of systematic and sustained epidemiologic and multidisciplinary research. This is important to prioritize hypotheses for testing in intervention studies in groups, and to refine tools for prognostication in individuals. Methodologic standards for the design, conduct, analysis and reporting of prognosis research are required. Training is needed for the clinicians, policymakers, and payers who use prognostic information.
CONCLUSION: Here, arguments detracting from the potential scope of prognosis research are rebutted and misconceptions addressed with the aim of stimulating debate on the evolving role of prognosis research.

Entities:  

Mesh:

Year:  2006        PMID: 17098565     DOI: 10.1016/j.jclinepi.2006.02.005

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  15 in total

1.  Survival prediction for terminally ill cancer patients: revision of the palliative prognostic score with incorporation of delirium.

Authors:  Emanuela Scarpi; Marco Maltoni; Rosalba Miceli; Luigi Mariani; Augusto Caraceni; Dino Amadori; Oriana Nanni
Journal:  Oncologist       Date:  2011-10-31

2.  Quality of acute coronary care in emerging economies.

Authors:  Martin Bobak; Harry Hemingway
Journal:  CMAJ       Date:  2009-06-09       Impact factor: 8.262

Review 3.  Prognosis of stable angina pectoris: why we need larger population studies with higher endpoint resolution.

Authors:  Adam D Timmis; Gene Feder; Harry Hemingway
Journal:  Heart       Date:  2006-09-04       Impact factor: 5.994

Review 4.  Reporting performance of prognostic models in cancer: a review.

Authors:  Susan Mallett; Patrick Royston; Rachel Waters; Susan Dutton; Douglas G Altman
Journal:  BMC Med       Date:  2010-03-30       Impact factor: 8.775

5.  Sickness absence as a prognostic marker for common chronic conditions: analysis of mortality in the GAZEL study.

Authors:  M Kivimäki; J Head; J E Ferrie; A Singh-Manoux; H Westerlund; J Vahtera; A Leclerc; M Melchior; A Chevalier; K Alexanderson; M Zins; M Goldberg
Journal:  Occup Environ Med       Date:  2008-07-08       Impact factor: 4.402

Review 6.  Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis.

Authors:  Hesborn Wao; Rahul Mhaskar; Ambuj Kumar; Branko Miladinovic; Benjamin Djulbegovic
Journal:  Syst Rev       Date:  2013-02-04

7.  The assessment of the prognosis of musculoskeletal conditions in older adults presenting to general practice: a research protocol.

Authors:  Christian D Mallen; George Peat; Elaine Thomas; Simon Wathall; Tracy Whitehurst; Charlotte Clements; Joanne Bailey; Jacqueline Gray; Peter R Croft
Journal:  BMC Musculoskelet Disord       Date:  2006-11-10       Impact factor: 2.362

8.  Assessing the cost effectiveness of using prognostic biomarkers with decision models: case study in prioritising patients waiting for coronary artery surgery.

Authors:  Martin Henriksson; Stephen Palmer; Ruoling Chen; Jacqueline Damant; Natalie K Fitzpatrick; Keith Abrams; Aroon D Hingorani; Ulf Stenestrand; Magnus Janzon; Gene Feder; Bruce Keogh; Martin J Shipley; Juan-Carlos Kaski; Adam Timmis; Mark Sculpher; Harry Hemingway
Journal:  BMJ       Date:  2010-01-19

9.  Discussing prognosis with older people with musculoskeletal pain: a cross-sectional study in general practice.

Authors:  Christian David Mallen; George Peat
Journal:  BMC Fam Pract       Date:  2009-07-07       Impact factor: 2.497

Review 10.  Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond.

Authors:  R D Riley; W Sauerbrei; D G Altman
Journal:  Br J Cancer       Date:  2009-04-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.